Recruiting

SH-RegistrySafety and Performance of Abbott Structural Heart Devices

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Congenital Abnormalities+7

+ Cardiovascular Diseases

+ Heart Defects, Congenital

+4 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: August 2024
See protocol details

Summary

Principal SponsorAbbott Medical Devices
Study ContactLaetitia BeullensMore contacts
Last updated: January 31, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: August 21, 2024

Actual date on which the first participant was enrolled.

The Abbott Structural Heart Device Registry is a study focused on understanding how well Abbott's heart devices perform and how safe they are when used in everyday hospital settings. This study involves patients who are receiving these devices as part of their standard medical care. It aims to include around 500 participants each year over a minimum of five years. This research is critical because it helps ensure that these devices, used in heart procedures, work effectively and safely for patients around the world. By doing so, the study aims to improve heart treatment options and outcomes for patients who need these devices. Participants in this study will have their data collected after they consent and undergo a procedure involving an Abbott heart device. The study tracks how well the procedures go by measuring the number of successful device implants and monitors potential safety concerns by noting any serious health issues related to the device or procedure within a week afterward. Follow-up visits are scheduled based on the type of device used, ranging from a few months to up to ten years in some cases. These visits can happen in person, over the phone, or virtually, depending on what is standard for the patient's hospital. Additionally, data from European sites are collected to support approval for specific heart valve sizes in the U.S.

Official TitleAbbott Structural Heart Device Registry
NCT06590467
Principal SponsorAbbott Medical Devices
Study ContactLaetitia BeullensMore contacts
Last updated: January 31, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

2500 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Congenital AbnormalitiesCardiovascular DiseasesHeart Defects, CongenitalHeart DiseasesHeart Septal DefectsHeart Septal Defects, AtrialHeart Valve DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCardiovascular AbnormalitiesForamen Ovale, Patent

Criteria

3 inclusion criteria required to participate
Subject is expected to undergo an implant attempt using one or more Abbott Structural Heart devices covered in this Registry or has previously undergone an implant attempt within the timeframes specified in the device-specific appendices.

Subject is willing and able to comply with the site's standard of care follow-up schedule.

Subject is willing to provide appropriate informed consent for Registry participation. For deceased subjects enrolled retrospectively, local regulations and EC/IRB recommendations regarding consent and the protection of personal data must be followed.

1 exclusion criteria prevent from participating
1. Subject is participating in another clinical study that would affect the results of this Registry.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 27 locations

Recruiting

Odense University Hospital

Odense, DenmarkOpen Odense University Hospital in Google Maps
Recruiting

Tartu University Hospital

Tartu, Estonia
Recruiting

CHRU Hopital de Pontchaillou

Rennes, France
Recruiting

Centre Médico Chirurgical Marie Lannelongue

Le Plessis-Robinson, France
Recruiting
27 Study Centers
SH-Registry | Safety and Performance of Abbott Structural Heart Devices | PatLynk